Beijing Gene+ Technology Funding: $220M Raised, Series D
Beijing Gene+ Technology is based in Beijing, China. It has raised $220M in total funding. Latest round: Series D.
Beijing Gene+ Technology funding overview
Beijing Gene+ Technology is based in Beijing, China. Beijing Gene+ Technology has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2025. The round record for Beijing Gene+ Technology runs through 2025; nothing later has been disclosed. Investors on record include Huagai Capital, WisdoMont Asset Management, Notable Capital, CCB International, AliHealth, Baidu Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Frequently asked about Beijing Gene+ Technology funding
How much has Beijing Gene+ Technology raised?
Beijing Gene+ Technology has raised $220M in total disclosed funding across the rounds on record.
Who has invested in Beijing Gene+ Technology?
Huagai Capital, WisdoMont Asset Management, Notable Capital, CCB International, AliHealth, Baidu Ventures are named among the investors backing Beijing Gene+ Technology.
What was the latest Beijing Gene+ Technology funding round?
The most recent disclosed round is a Series D, announced in December 2025.
Where is Beijing Gene+ Technology based?
Beijing Gene+ Technology is based in Beijing, China.
When did Beijing Gene+ Technology last raise?
The last disclosed Beijing Gene+ Technology round closed in December 2025 at Series D.
Totals shown for Beijing Gene+ Technology aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.
Companies related to Beijing Gene+ Technology (26)
